Target Market: Infectious Disease Medical professionals

Learning Objectives: Participants should be able to: after completing this program

Determine how to treat and manage infectious diseases clinically.
Show that you can identify a number of infectious diseases that are widespread.
Recognize essential noninfectious etiologies and key differential diagnostic methods.
Recognize the management and treatment of various parasites, such as helminthes and protozoa.
Show a better understanding of infectious disease concepts and practices, such as those pertaining to bioterrorism, viral disease, bacterial infections, immunology, STIs, fungi, parasites, and mycobacteria.
Statement of Designation:
Release date: January 21, 2018, Termination date: January 20, 2021; Online Course V3.1
This continuing education is approved for a maximum of 48.5 AMA PRA Category 1 CreditsTM by the PeerPoint Medical Education Institute. Doctors should only submit credit claims that are appropriate for the level of their involvement in the activity.​

HIGH-YIELD CONTENT LECTURES FOCUSED ON LASER: You can quickly and simply learn the information for the ABIM® exam by taking the Pass Machine Infectious Disease board review course. This course includes an extensive collection of condensed video lectures that are well matched to the format of the infectious disease MOC and infectious disease certification exams. In this manner, you’ll concentrate on every exam topic and keyword without wasting any time.

The Question-Based Learning (or “QBL”) method guarantees that the material you examine is entirely pertinent to the ABIM® Infectious Disease exam. This tried-and-true technique allows you to examine a topic before answering a multiple-choice question by combining it with relevant lectures.

EXPERIENCED BOARD FACILTY: Board-certified instructors with experience teaching infectious disease board exam preparation offer the infectious disease certification and MOC courses. Every lecture is therefore completely board-relevant, current, and accurate from a medical standpoint.

INFECTIOUS DISEASE STUDY GUIDE: With the help of this study guide, you may easily follow along with lectures, take notes, and conduct offline research. The entire course syllabus, along with all cited slides, pictures, diagrams, and infographics, is included in the PDF.

Subjects:

01A Acute Pericarditis and Vascular Infections Diagnosis of Cardiovascular Infections
01B Infections Related to the Heart Differential Diagnosis of Endocarditis, Diagnostic Approach, and Native Valve Endocarditis
01C Prophylaxis of Infectious Endocarditis, Prosthetic Valve Endocarditis, and Pacemaker Infection in Cardiovascular Infections
02A Significant Correlation Between Streptococcal Infections and Gram-Positive Bacteria
02B Positive Gram Bacteria Severe Staphylococcal Infections and Streptococci Classification
03A Handling Resistance to Antibiotics Mechanism of Resistance in Gram-Positive Infections: Laboratory Diagnosis and Antibiotic Management
03B Handling Gram-positive Infections Resistant to Antibiotics Antibiotics that are Gram Positive
Acute Bacterial Meningitis, Empiric Antibiotic Therapy, Antibiotics Covering Listeria, Etiology and Management of Meningitis and Neurosurgery are all covered in 04A CNS Bacterial Infections.
04B Bacterial Infections of the Brain Brain Abscess and Infection of the CNS Shunt
05A Respiratory Bacterial Infections: Pertussis, Non-Resolving Pneumonia, and Empyema of Pleural Effusion
05B Respiratory Bacterial Infections: Common Mistakes to Avoid in the Identification and Treatment of Ventilator-Associated Pneumonia and CAP
06A GI Tract Infections Common Food-Borne Illness Etiologies, Uncommon Pathogens, and Non-Infectious Food-Borne Illness Etiologies
GI Tract Infections, 06B Managing Drug Resistance and Clostridium difficile with Helicobacter pylori
The etiology and management of intraabdominal bacterial infections, cholangitis and cholecystitis, and complications associated with acute pancreatitis are covered in 07A.
07B Bacterial Infections Within the Abdomen Infection from Surgical Wounds and Peritonitis
Aeromonas and Leeches, DD, and Bacterial Skin and Soft Tissue Infections Following Water Exposure
08B Bacterial Infections of the Skin and Soft Tissues Necrotizing fasciitis, tetanus, infections caused by bites, and staphylococcal and streptococcal infections
09A Handling Gram-Negative Infections Resistant to Antibiotics I
09B Handling Gram-Negative Infections Resistant to Antibiotics II
10A Melioidosis and Typhoid Fever
Bacterial Zoonoses 10B
11A Superior Bacteria
11B Infections with Spirochetes
12A Severe ENT Infections Complicated Sinusitis in Head and Neck Cancer Patients, Including Invasive Fungal Sinusitis and Mandibular Osteoradionecrosis
12B Severe ENT Infections Diphtheria, Neck Space Infections, and Malignant Otitis Externa
13A Sepsis and Septic Shock
13B Approach to Fever in the Hospital and Classic FUO Including Non-Infectious Etiologies
14A Acute Febrile Illness With Rash
14B Non-Infectious Etiologies of Fever and Rash
15A Syphilis and Other Ulcerative STIs
15B Non-Ulcerative STIs and Complications of STIs
16A Natural History, Prevention, and Post-exposure Prophylaxis
16B Epidemiology, Diagnosis, and Acute HIV Infection
17A Antiviral Therapy Initial Regimens, First Regimen Failure, and Major Adverse Effects of ART
17B Antiviral Therapy Major Drug Interactions and HLA B-5701 and Co-receptor Tropism
18A Opportunistic Infections Major OIs I
18B Opportunistic Infections Major OIs II and IRIS
18C Opportunistic Infections OI Prophylaxis
19A Malignancy Associated With HIV and AIDS AIDS-Defining Malignancy and Non-AIDS Defining Malignancy
19B Malignancy Associate With HIV and AIDS Prevention of Malignancy in HIV
20A Coinfections and Other Complications of HIV-AIDS Coinfection with Hepatitis B and Hepatitis C and Coinfection with Tuberculosis
20B Coinfections and Other Complications of HIV-AIDS Other HIV Issues, Cardiovascular Complications, and Other Metabolic Complications
21A Management of Infections in Pregnancy I
21B Management of Infections in Pregnancy II
22A Dengue, Yellow Fever, Chikungunya, and Zika
22B Hantaviruses
23A Hemorrhagic Fevers Flaviviruses and Bunyaviridae
23B Hemorrhagic Fevers Arenaviruses and Filoviruses
24A Herpes Virus Infections CMV, EBV, VZV, and HSV
24B Herpes Virus Infections HHV-6, HHV-8, and Herpes Simiae B Virus
24C Herpes Virus Infections Herpesviridae in Immunocompromised Hosts
25A Viral Respiratory Infections Influenza With Prevention and Parainfluenza and Other Common Respiratory Viruses
25B Viral Respiratory Infections SARS and MERS and Avian Influenza
26A Childhood Viruses in Adults and Emerging Viruses I
26B Childhood Viruses in Adults and Emerging Viruses II
27A Ehrlichiosis and Anaplasmosis
27B Rickettsia and Orientia
28A Tuberculosis Monoinfection
28B Tuberculosis Mycobacteriology
29A Non-Tuberculosis Mycobacteria Rapid Growers, M. avium Complex, and M. kansasii
29B Non-Tuberculosis Mycobacteria and Leprosy M. marinum, M. hemophilum, M. ulcerens, and Leprosy
30A Intestinal Protozoa, Trichomonas, Toxoplasmosis and Free-Living Amebae I
30B Intestinal Protozoa, Trichomonas, Toxoplasmosis and Free-Living Amebae II
31A Invasive Intracellular Protozoa Malaria, Babesiosis, and American and African Trypanosomiasis
31B Invasive Intracellular Protozoa Visceral and Cutaneous and Mucocutaneous Leishmaniasis
32A Trematodes Schistosomiasis, Opisthorchis, and Fasciola
32B Cestodes Tapeworms, Cysticercosis, and Echinococcosis
33A Nematodes Filariases, Guinea Worm and Trichinosis
33B Nematodes Intestinal Nematodes
34A Endemic Fungi Histo, Blasto, and Cocci and Paracocci
34B Endemic Fungi Sporotrichosis, Penicillium Marneffei, and African Histo Duboisii
35A Opportunistic Fungal Infections I
35B Opportunistic Fungal Infections II
36A Antifungal Agents Amphotericin B and Azole Antifungal Agents
36B Antifungal Agents Echinocandins, Flucytosine, and Drug Interactions
37A Primary Immune Deficiency
37B Non-HIV Related Secondary Immune Deficiency
38A Routine Immunizations and Pre-Travel Immunizations
38B Rabies Vaccine and Post-Exposure Prophylaxis
39A Neutropenia and Approach to Neutropenic Fever
39B Hematopoietic Stem Cell Transplantations
40A Infections in Solid Organ Transplantation
40B Infections with Biologicals for Treatment of Autoimmune and Idiopathic Diseases
41A Bioterrorism Anthrax, Botulism, and Smallpox
41B Bioterrorism Plague and Tularemia
42A Hospital Epidemiology Preventing Infections in the Hospital Environment
42B Hospital Epidemiology Surveillance of HAIs and Antibiotic Stewardship
43A Infection Control Isolation Precautions and Vaccination of Healthcare Workers
43B Infection Control Prevention of Tuberculosis Transmission and Hand Hygiene